207 related articles for article (PubMed ID: 28924108)
1. Proton Pump Inhibitor Induction of Gastric Cobblestone-like Lesions in the Stomach.
Takahari K; Haruma K; Ohtani H; Kiyoto S; Watanabe A; Kamada T; Manabe N; Hatano Y
Intern Med; 2017 Oct; 56(20):2699-2703. PubMed ID: 28924108
[TBL] [Abstract][Full Text] [Related]
2. Endoscopic findings of the gastric mucosa during long-term use of proton pump inhibitor - a multicenter study.
Kiso M; Ito M; Boda T; Kotachi T; Masuda K; Hata K; Sasaki A; Kawamura T; Yoshihara M; Tanaka S; Chayama K
Scand J Gastroenterol; 2017 Aug; 52(8):828-832. PubMed ID: 28485638
[TBL] [Abstract][Full Text] [Related]
3. GASTRIC FUNDIC GLAND POLYPS: CAN HISTOLOGY BE USEFUL TO PREDICT PROTON PUMP INHIBITORS USE?
Brito HLF; Barros C; Freire MV; Silva Filho MND; Nascimento TV
Arq Gastroenterol; 2018; 55(4):380-384. PubMed ID: 30785522
[TBL] [Abstract][Full Text] [Related]
4. Hemorrhagic polyps formed like fundic gland polyps during long-term proton pump inhibitor administration.
Takeda T; Asaoka D; Tajima Y; Matsumoto K; Takeda N; Hiromoto T; Okubo S; Saito H; Aoyama T; Shibuya T; Sakamoto N; Hojo M; Osada T; Nagahara A; Yao T; Watanabe S
Clin J Gastroenterol; 2017 Oct; 10(5):478-484. PubMed ID: 28660530
[TBL] [Abstract][Full Text] [Related]
5. Histological analysis of fundic gland polyps secondary to PPI therapy.
Fukuda M; Ishigaki H; Sugimoto M; Mukaisho KI; Matsubara A; Ishida H; Moritani S; Itoh Y; Sugihara H; Andoh A; Ogasawara K; Murakami K; Kushima R
Histopathology; 2019 Oct; 75(4):537-545. PubMed ID: 31087669
[TBL] [Abstract][Full Text] [Related]
6. Adenocarcinoma arising in multiple hyperplastic polyps in a patient with Helicobacter pylori infection and hypergastrinemia during long-term proton pump inhibitor therapy.
Anjiki H; Mukaisho KI; Kadomoto Y; Doi H; Yoshikawa K; Nakayama T; Vo DT; Hattori T; Sugihara H
Clin J Gastroenterol; 2017 Apr; 10(2):128-136. PubMed ID: 28160247
[TBL] [Abstract][Full Text] [Related]
7. Proton-pump inhibitor-induced fundic gland polyps with hematemesis.
Tanaka M; Kataoka H; Yagi T
Clin J Gastroenterol; 2019 Apr; 12(2):193-195. PubMed ID: 30251013
[TBL] [Abstract][Full Text] [Related]
8. Gastric neuroendocrine tumours from long-term proton pump inhibitor users are indolent tumours with good prognosis.
Trinh VQ; Shi C; Ma C
Histopathology; 2020 Dec; 77(6):865-876. PubMed ID: 32702178
[TBL] [Abstract][Full Text] [Related]
9. Helicobacter gastritis induces changes in the oxyntic mucosa indistinguishable from the effects of proton pump inhibitors.
Kumar KR; Iqbal R; Coss E; Park C; Cryer B; Genta RM
Hum Pathol; 2013 Dec; 44(12):2706-10. PubMed ID: 24071014
[TBL] [Abstract][Full Text] [Related]
10. Proton Pump Inhibitor-Related Gastric Mucosal Changes.
Kim GH
Gut Liver; 2021 Sep; 15(5):646-652. PubMed ID: 32327613
[TBL] [Abstract][Full Text] [Related]
11. Serum gastrin and chromogranin A levels in patients with fundic gland polyps caused by long-term proton-pump inhibition.
Fossmark R; Jianu CS; Martinsen TC; Qvigstad G; Syversen U; Waldum HL
Scand J Gastroenterol; 2008 Jan; 43(1):20-4. PubMed ID: 18938772
[TBL] [Abstract][Full Text] [Related]
12. Black Spot, a Novel Gastric Finding Potentially Induced by Proton Pump Inhibitors.
Hatano Y; Haruma K; Ayaki M; Kamada T; Ohtani H; Murao T; Manabe N; Mori H; Masaki T; Shiotani A
Intern Med; 2016; 55(21):3079-3084. PubMed ID: 27803398
[TBL] [Abstract][Full Text] [Related]
13. Long-term proton pump inhibitor (PPI) use and the development of gastric pre-malignant lesions.
Song H; Zhu J; Lu D
Cochrane Database Syst Rev; 2014 Dec; 2014(12):CD010623. PubMed ID: 25464111
[TBL] [Abstract][Full Text] [Related]
14. Gastric mucosal cracked and cobblestone-like changes resulting from proton pump inhibitor use.
Miyamoto S; Kato M; Tsuda M; Matsuda K; Muranaka T; Abiko S; Ono M; Mizushima T; Omori S; Yamamoto K; Mabe K; Ono S; Kudo T; Shimizu Y; Sakamoto N
Dig Endosc; 2017 May; 29(3):307-313. PubMed ID: 27859804
[TBL] [Abstract][Full Text] [Related]
15. Sporadic fundic gland polyp-related adenomas occurred in non-atrophic gastric mucosa without helicobacter pylori infection.
Tazaki S; Nozu F; Yosikawa N; Imawari M; Suzuki N; Tominaga K; Hoshino M; Suzuki S; Hayashi K
Dig Endosc; 2011 Apr; 23(2):182-6. PubMed ID: 21429026
[TBL] [Abstract][Full Text] [Related]
16. Hypergastrinemia in Long-Term Use of Proton Pump Inhibitors.
Shiotani A; Katsumata R; Gouda K; Fukushima S; Nakato R; Murao T; Ishii M; Fujita M; Matsumoto H; Sakakibara T
Digestion; 2018; 97(2):154-162. PubMed ID: 29310112
[TBL] [Abstract][Full Text] [Related]
17. Relative risk factors associated with the development of fundic gland polyps.
Huang CZ; Lai RX; Mai L; Zhou HL; Chen HJ; Guo HX
Eur J Gastroenterol Hepatol; 2014 Nov; 26(11):1217-21. PubMed ID: 25187299
[TBL] [Abstract][Full Text] [Related]
18. Endoscopic ultrasonography features of gastric mucosal cobblestone-like changes from a proton-pump inhibitor.
Miyamoto S; Kudo T; Kato M; Matsuda K; Abiko S; Tsuda M; Mizushima T; Yamamoto K; Ono S; Shimizu Y; Sakamoto N
Clin J Gastroenterol; 2017 Jun; 10(3):220-223. PubMed ID: 28265894
[TBL] [Abstract][Full Text] [Related]
19. The clinicopathological characteristics of gastric polyps and the relationship between fundic gland polyps, Helicobacter pylori infection, and proton pump inhibitors.
Gao W; Huang Y; Lu S; Li C
Ann Palliat Med; 2021 Feb; 10(2):2108-2114. PubMed ID: 33725768
[TBL] [Abstract][Full Text] [Related]
20. Case-control analysis of fundic gland polyps and proton-pump inhibitors. A pathologist's perspective.
Velazquez-Dohorn M; López-Durand CF; Candanedo-González F; Araujo-Villalvazo EA; Gamboa-Domínguez A
Rev Gastroenterol Mex (Engl Ed); 2020; 85(1):42-47. PubMed ID: 31126726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
